173 related articles for article (PubMed ID: 35756163)
1. Whole-genome circulating tumor DNA methylation landscape reveals sensitive biomarkers of breast cancer.
Hai L; Li L; Liu Z; Tong Z; Sun Y
MedComm (2020); 2022 Sep; 3(3):e134. PubMed ID: 35756163
[TBL] [Abstract][Full Text] [Related]
2. Whole-genome bisulfite sequencing analysis of circulating tumour DNA for the detection and molecular classification of cancer.
Gao Y; Zhao H; An K; Liu Z; Hai L; Li R; Zhou Y; Zhao W; Jia Y; Wu N; Li L; Ying J; Wang J; Xu B; Wu Z; Tong Z; He J; Sun Y
Clin Transl Med; 2022 Aug; 12(8):e1014. PubMed ID: 35998020
[TBL] [Abstract][Full Text] [Related]
3. Circulating ctDNA methylation quantification of two DNA methyl transferases in papillary thyroid carcinoma.
Khatami F; Teimoori-Toolabi L; Heshmat R; Nasiri S; Saffar H; Mohammadamoli M; Aghdam MH; Larijani B; Tavangar SM
J Cell Biochem; 2019 Oct; 120(10):17422-17437. PubMed ID: 31127647
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA).
Liang W; Zhao Y; Huang W; Gao Y; Xu W; Tao J; Yang M; Li L; Ping W; Shen H; Fu X; Chen Z; Laird PW; Cai X; Fan JB; He J
Theranostics; 2019; 9(7):2056-2070. PubMed ID: 31037156
[No Abstract] [Full Text] [Related]
5. Computational challenges in detection of cancer using cell-free DNA methylation.
Sharma M; Verma RK; Kumar S; Kumar V
Comput Struct Biotechnol J; 2022; 20():26-39. PubMed ID: 34976309
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of circulating tumor DNA by electropherogram analysis and methylome profiling in high-risk neuroblastomas.
Trinidad EM; Juan-Ribelles A; Pisano G; Castel V; Cañete A; Gut M; Heath S; Font de Mora J
Front Oncol; 2023; 13():1037342. PubMed ID: 37251933
[TBL] [Abstract][Full Text] [Related]
7. Multimodal analysis of genome-wide methylation, copy number aberrations, and end motif signatures enhances detection of early-stage breast cancer.
Pham TMQ; Phan TH; Jasmine TX; Tran TTT; Huynh LAK; Vo TL; Nai THT; Tran TT; Truong MH; Tran NC; Nguyen VTC; Nguyen TH; Nguyen THH; Le NDK; Nguyen TD; Nguyen DS; Truong DK; Do TTT; Phan MD; Giang H; Nguyen HN; Tran LS
Front Oncol; 2023; 13():1127086. PubMed ID: 37223690
[TBL] [Abstract][Full Text] [Related]
8. Prediction of blood-based biomarkers and subsequent design of bisulfite PCR-LDR-qPCR assay for breast cancer detection.
Bacolod MD; Huang J; Giardina SF; Feinberg PB; Mirza AH; Swistel A; Soper SA; Barany F
BMC Cancer; 2020 Jan; 20(1):85. PubMed ID: 32005108
[TBL] [Abstract][Full Text] [Related]
9. Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing.
Li Z; Guo X; Tang L; Peng L; Chen M; Luo X; Wang S; Xiao Z; Deng Z; Dai L; Xia K; Wang J
Tumour Biol; 2016 Oct; 37(10):13111-13119. PubMed ID: 27449045
[TBL] [Abstract][Full Text] [Related]
10. Pan-cancer landscape of abnormal ctDNA methylation across human tumors.
Bai Y; Qu D; Lu D; Li Y; Zhao N; Cui G; Li X; Sun X; Sun H; Zhao L; Li Q; Zhang Q; Han T; Wang S; Yang Y
Cancer Genet; 2022 Nov; 268-269():37-45. PubMed ID: 36152512
[TBL] [Abstract][Full Text] [Related]
11. Parallel Analyses of Somatic Mutations in Plasma Circulating Tumor DNA (ctDNA) and Matched Tumor Tissues in Early-Stage Breast Cancer.
Zhang X; Zhao W; Wei W; You Z; Ou X; Sun M; Yin Y; Tang X; Zhao Z; Hu C; Liu F; Deng J; Mao L; Zhou D; Ren Y; Li X; Zhang S; Liu C; Geng J; Yao G; Song B; Liu Y; Li D; Jiang Y; Chen Y; Zhao Y; Yu S; Pang D
Clin Cancer Res; 2019 Nov; 25(21):6546-6553. PubMed ID: 31350313
[TBL] [Abstract][Full Text] [Related]
12. Development of a liquid biopsy based purely quantitative digital droplet PCR assay for detection of MLH1 promoter methylation in colorectal cancer patients.
Wang D; O'Rourke D; Sanchez-Garcia JF; Cai T; Scheuenpflug J; Feng Z
BMC Cancer; 2021 Jul; 21(1):797. PubMed ID: 34243735
[TBL] [Abstract][Full Text] [Related]
13. Methylation analyses in liquid biopsy.
Lissa D; Robles AI
Transl Lung Cancer Res; 2016 Oct; 5(5):492-504. PubMed ID: 27826530
[TBL] [Abstract][Full Text] [Related]
14. Development and initial clinical correlation of a DNA methylation-based blood test for prostate cancer.
Carson JJK; Di Lena MA; Berman DM; Siemens DR; Mueller CR
Prostate; 2020 Sep; 80(12):1038-1042. PubMed ID: 32506642
[TBL] [Abstract][Full Text] [Related]
15. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC).
Pu W; Wang C; Chen S; Zhao D; Zhou Y; Ma Y; Wang Y; Li C; Huang Z; Jin L; Guo S; Wang J; Wang M
Clin Epigenetics; 2017; 9():129. PubMed ID: 29270239
[TBL] [Abstract][Full Text] [Related]
16. Early detection and prognosis prediction for colorectal cancer by circulating tumour DNA methylation haplotypes: A multicentre cohort study.
Mo S; Dai W; Wang H; Lan X; Ma C; Su Z; Xiang W; Han L; Luo W; Zhang L; Wang R; Zhang Y; Zhang W; Yang L; Lu R; Guo L; Zheng Y; Huang M; Xu Y; Liang L; Cai S; Cai G
EClinicalMedicine; 2023 Jan; 55():101717. PubMed ID: 36386039
[TBL] [Abstract][Full Text] [Related]
17. Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencing.
Zhang H; Dong P; Guo S; Tao C; Chen W; Zhao W; Wang J; Cheung R; Villanueva A; Fan J; Ding H; Schrodi SJ; Zhang D; Zeng C
BMC Med; 2020 Aug; 18(1):200. PubMed ID: 32741373
[TBL] [Abstract][Full Text] [Related]
18. Integrative Analysis of DNA Methylation and Gene Expression to Determine Specific Diagnostic Biomarkers and Prognostic Biomarkers of Breast Cancer.
Zhang M; Wang Y; Wang Y; Jiang L; Li X; Gao H; Wei M; Zhao L
Front Cell Dev Biol; 2020; 8():529386. PubMed ID: 33365308
[No Abstract] [Full Text] [Related]
19. Highly Specific Droplet-Digital PCR Detection of Universally Methylated Circulating Tumor DNA in Endometrial Carcinoma.
Beinse G; Borghese B; Métairie M; Just PA; Poulet G; Garinet S; Parfait B; Didelot A; Bourreau C; Agueeff N; Lavollé A; Terris B; Chapron C; Goldwasser F; Leroy K; Blons H; Laurent-Puig P; Taly V; Alexandre J
Clin Chem; 2022 Jun; 68(6):782-793. PubMed ID: 35323926
[TBL] [Abstract][Full Text] [Related]
20. Analyzing the cancer methylome through targeted bisulfite sequencing.
Lee EJ; Luo J; Wilson JM; Shi H
Cancer Lett; 2013 Nov; 340(2):171-8. PubMed ID: 23200671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]